Details for 2017156985
Up to date per 03.04.2026
Actions
Details for 2017156985
Granted/Registered
European Patent
27.09.2017 A
20.01.2021 B1
03.12.2010
US
419395 P
A61K 31/485 20060101AFI20170622BHEP
Owner
Nalpropion Pharmaceuticals LLC10 North Park Place, Suite 201 Morristown, NJ 07960US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
FLANAGAN, Shawn14083 Via Corsini San Diego, CA 92128US
DUNAYEVICH, Eduardo1030 Deep Wood Drive Westlake Village, CA 91362US
Information about Fees